1. Home
  2. SLE vs DCOY Comparison

SLE vs DCOY Comparison

Compare SLE & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Super League Enterprise Inc.

SLE

Super League Enterprise Inc.

HOLD

Current Price

$3.11

Market Cap

5.0M

ML Signal

HOLD

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$6.23

Market Cap

4.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SLE
DCOY
Founded
2014
N/A
Country
United States
United States
Employees
N/A
11
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
SLE
DCOY
Price
$3.11
$6.23
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$60.00
$30.00
AVG Volume (30 Days)
47.5K
12.6K
Earning Date
05-14-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,064,000.00
N/A
Revenue This Year
$24.86
N/A
Revenue Next Year
$49.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
90.41
N/A
52 Week Low
$0.48
$0.53
52 Week High
$11.43
$9.57

Technical Indicators

Market Signals
Indicator
SLE
DCOY
Relative Strength Index (RSI) 40.72 46.44
Support Level $0.51 $4.98
Resistance Level $3.43 $6.47
Average True Range (ATR) 0.24 0.78
MACD -0.00 -0.09
Stochastic Oscillator 32.73 32.53

Price Performance

Historical Comparison
SLE
DCOY

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: